- Report
- February 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 75 Pages
Israel
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 74 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2022
- 121 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 118 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 129 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- July 2022
- 85 Pages
Belgium
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2021
- 293 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2022
- 120 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- November 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 84 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2023
- 83 Pages
Israel
From €3327EUR$3,500USD£2,795GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €14255EUR$14,995USD£11,976GBP

The ACE Inhibitor market is a segment of the pharmaceutical industry that focuses on drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. ACE inhibitors are a type of medication that works by blocking the action of an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a hormone called angiotensin II, which can cause blood vessels to narrow and increase blood pressure. By blocking the action of ACE, ACE inhibitors can help reduce blood pressure and improve the symptoms of heart failure.
ACE inhibitors are typically prescribed in combination with other medications, such as diuretics, beta-blockers, and calcium channel blockers. They are also used to treat other conditions, such as kidney disease, diabetes, and migraines.
Some companies in the ACE Inhibitor market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more